BRF
GCVRZ

B. Riley Financial’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

B. Riley Financial’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-256,219
Closed -$144K – 63
2019
Q3 		$144K Buy
256,219
+14,814
+6% +$7.97K 0.05% 42
2019
Q2 		$126K Hold
241,405
– – 0.06% 36
2019
Q1 		$109K Buy
241,405
+30,000
+14% +$14K 0.04% 79
2018
Q4 		$101K Buy
211,405
+11,388
+6% +$5.66K 0.06% 91
2018
Q3 		$106K Sell
200,017
-44,754
-18% -$24K 0.03% 178
2018
Q2 		$122K Buy
+244,771
New +$114K 0.03% 293
2018
Q1 		– Sell
-200,046
Closed -$76K – 356
2017
Q4 		$76K Buy
200,046
+84,463
+73% +$32K 0.02% 297
2017
Q3 		$42K Buy
+115,583
New +$42.8K 0.01% 299

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

B. Riley Financial's GCVRZ Position: Q4 2019 in Review

B. Riley Financial sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 256,219 shares — an estimated $144K sold.

B. Riley Financial first reported a position in GCVRZ in Q3 2017 and held it in 8 quarters. The position peaked at $144K in Q3 2019. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • B. Riley Financial reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • B. Riley Financial sold 256,219 Sanofi Contingent Value Rights shares in Q4 2019, an estimated $144K.
  • B. Riley Financial first reported a position in Sanofi Contingent Value Rights in Q3 2017 and held it in 8 quarters.
  • B. Riley Financial's Sanofi Contingent Value Rights position peaked at $144K in Q3 2019.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on B. Riley Financial's 13F filing for Q4 2019, filed 5 Feb 2020.